Curr Hematol Malig Rep. 2010 Apr;5(2):109-17.

The role of molecular tests in acute myelogenous leukemia treatment decisions.

Source

Dana-Farber Cancer Institute, Boston, MA 02115, USA. gmotyckova@partners.org

Abstract

The prognosis for patients with acute myelogenous leukemia (AML) is dependent on age, karyotype, and the genetics of the neoplastic cell. The molecular markers with prognostic impact include mutations in FLT3, NPM1, MLL, WT1, c-KIT, and expression levels of BAALC, NM1, ERG, and CXCR4. Gene expression profiles and microRNA expression patterns in AML may prove highly useful in defining the prognosis of AML. Cytogenetic and, increasingly, molecular findings are used in determining the best therapy for AML patients, especially the choice of whether to perform allogeneic stem cell transplantation.

PMID:: 20425404; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Risk assessment in patients with acute myeloid leukemia and a normal karyotype. [Clin Cancer Res. 2005]
Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T. Clin Cancer Res. 2005 Feb 15; 11(4):1416-24.
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. [J Clin Oncol. 2008]
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Paschka P, Marcucci G, Ruppert AS, Whitman SP, Mrózek K, Maharry K, Langer C, Baldus CD, Zhao W, Powell BL, et al. J Clin Oncol. 2008 Oct 1; 26(28):4595-602. Epub 2008 Jun 16.
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. [Blood. 2008]
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Langer C, Radmacher MD, Ruppert AS, Whitman SP, Paschka P, Mrózek K, Baldus CD, Vukosavljevic T, Liu CG, Ross ME, et al. Blood. 2008 Jun 1; 111(11):5371-9. Epub 2008 Mar 31.
Review Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? [Blood. 2007]
Review Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
Mrózek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Blood. 2007 Jan 15; 109(2):431-48. Epub 2006 Sep 7.
Review Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. [J Hematol Oncol. 2009]
Review Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.
Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W. J Hematol Oncol. 2009 Jun 2; 2:23. Epub 2009 Jun 2.

See reviews... See all...

Cited by 1 PubMed Central article

Chromosomal aberrations in hematological malignancies: A guide to the identification of novel oncogenes. [Indian J Hum Genet. 2011]
Chromosomal aberrations in hematological malignancies: A guide to the identification of novel oncogenes.
Vundinti BR, Ghosh K. Indian J Hum Genet. 2011 May; 17(2):43-4.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The role of molecular tests in acute myelogenous leukemia treatment decisions.
The role of molecular tests in acute myelogenous leukemia treatment decisions.
Curr Hematol Malig Rep. 2010 Apr ;5(2):109-17.

PubMed
The role of MeCP2 in brain development and neurodevelopmental disorders.
The role of MeCP2 in brain development and neurodevelopmental disorders.
Curr Psychiatry Rep. 2010 Apr ;12(2):127-34.

PubMed
Relapse prevention in childhood depression.
Relapse prevention in childhood depression.
Curr Psychiatry Rep. 2010 Apr ;12(2):85-7.

PubMed
Chronic headaches and the neurobiology of somatization.
Chronic headaches and the neurobiology of somatization.
Curr Pain Headache Rep. 2010 Feb ;14(1):55-61.

PubMed
Temperature and the seasonality of births.
Temperature and the seasonality of births.
Adv Exp Med Biol. 1991 ;286:73-88.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: